| View |
|
DRP-13346
|
Epinephrine
|
Maxiphrine
|
1mg/mL
|
Solution For Injection (IM/IV/SC)
|
-
|
Maxitech Pharma (Pvt) Ltd.
|
Pakistan
|
Initial
|
01 February 2023
|
01 February 2028
|
| View |
|
DRP-13350
|
DYDROGESTERONE
|
DYDROGEST
|
10mg
|
Film-Coated Tablet
|
Progestogen (Pregnadien Derivative)
|
Par Laboratories
|
India
|
Renewal
|
23 August 2024
|
01 February 2030
|
| View |
|
HRP-562
|
Methyl Salicylate + Eucalyptus Oil+ Menthol + Camphor
|
None
|
10.00 mL/ 7.50 mL/1.25g/1.00g per 100 mL
|
|
-
|
Shanne Herbal Manufacturing
|
Philippines
|
Initial
|
03 February 2023
|
03 February 2028
|
| View |
|
DRP-13343
|
Ascorbic Acid + Zinc
|
Maxicor® Plus Tab
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/
10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Film Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
31 January 2023
|
31 January 2028
|
| View |
|
DRP-13341
|
Ascorbic Acid + Zinc
|
Xtracee Plus® Tab
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/
10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
31 January 2023
|
31 January 2028
|
| View |
|
DRP-13342
|
Ascorbic Acid + Zinc
|
CGEN Plus Tab
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/ 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
31 January 2023
|
31 January 2028
|
| View |
|
DRP-13317
|
Ascorbic Acid
|
Ascorgen® Cap
|
1 g
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
26 January 2023
|
26 January 2028
|
| View |
|
DRP-13318
|
Ascorbic Acid
|
Rapid C® Cap
|
1 g
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
26 January 2023
|
26 January 2028
|
| View |
|
DRP-13340
|
Ascorbic Acid
|
Immucap®
|
1 g
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
31 January 2023
|
31 January 2028
|
| View |
|
DRHR-2199
|
Isopropyl Alcohol
|
None
|
70% (v/v)
|
Solution
|
-
|
Telstar Manufacturing Corporation
|
Philippines
|
Initial(HR)
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48603
|
Ascorbic Acid
|
None
|
500 mg
|
Capsule
|
-
|
Northfield Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
06 February 2023
|
06 February 2028
|
| View |
|
DR-XY48604
|
Ascorbic Acid
|
None
|
500 mg
|
Tablet
|
-
|
Northfield Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
06 February 2023
|
06 February 2028
|
| View |
|
DRP-13319
|
Aluminum Hydroxide + Magnesium Hydroxide + Oxetacaine
|
None
|
582 mg/ 196mg/ 20mg per 10mL
|
Oral Suspension
|
-
|
Daewon Pharm. Co., Ltd.
|
Korea
|
Initial [OTC]
|
26 January 2023
|
26 January 2028
|
| View |
|
DRHR-2200
|
Isopropyl Alcohol
|
None
|
70% (v/v)
|
Solution
|
-
|
Telstar Manufacturing Corporation
|
Philippines
|
Initial (HR)
|
03 February 2023
|
03 February 2028
|
| View |
|
DRP-13362
|
Xylometazoline Hydrochloride
|
Zynasalo
|
10 mg/10mL
|
Nasal Spray
|
-
|
Ebe Pharmaceutical Co., Ltd.
|
China
|
Initial (OTC)
|
03 February 2023
|
03 February 2028
|
| View |
|
DRP-13351
|
Omeprazole (As Sodium)
|
Omerecid
|
40 mg
|
Lyophilized Powder For Injection (IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
02 February 2023
|
02 February 2028
|
| View |
|
DR-XY48599
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin -M 10 Forte
|
10mg/1 g
|
Film-Coated Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|
| View |
|
DR-XY48601
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin-M 5 Forte
|
5 mg/1 g
|
Film-Coated Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|
| View |
|
DRP-13333
|
Olmesartan
|
Olmax-20
|
20mg
|
Film-Coated Tablet
|
-
|
Evertogen Life Sciences Limited
|
India
|
Initial
|
27 January 2023
|
27 January 2028
|
| View |
|
DR-XY48602
|
Dapagliflozin + Metformin Hydrochloride (in extended-
release form)
|
Dapzin-M 5
|
5 mg /500 mg
|
Tablet
|
-
|
Micro Labs Limited
|
India
|
Monitored Release (Re-Application)
|
03 February 2023
|
03 February 2028
|